pharma news today glp-1 obesity The next phase of the drug race Obesity drugs have displaced oncology

Clinical studies indicate that women using certain GLP-1 treatments can achieve significant weight loss, often exceeding 15% of their total weight, with some reporting reductions of 20-25% within a year

Semaglutide: The Breakthrough GLP-1 Semaglutide was the first GLP-1 drug to show double-digit percentage weight loss in large clinical trials

Medical-Grade Full-Body Light Therapy What the Protocol Parameters Mean Not all light therapy is clinically equivalent

Some peptides survive the digestive tract and can be taken orally

While side effects such as nausea can occur, our providers personalize your dosing schedule to keep them to a minimum

The most commonly reported adverse events were gastrointestinal-related (GI), and even then, they were generally mild to moderate in severity